Skip to content

Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island

Epidemiological Monitoring of COVID-19 Patients Hospitalized on Reunion Island

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05413694
Acronym
COVIDEPI-SUIV'
Enrollment
450
Registered
2022-06-10
Start date
2022-07-31
Completion date
2024-12-31
Last updated
2022-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

The island of Reunion, a French overseas department of 860,000 inhabitants, located in the Indian Ocean (OI) zone, recorded its first case of COVID-19 on March 11, 2020. The epidemic, which was described as not very severe during the year 2020 in Reunion was much more intense and more deadly in 2021, with the arrival of the new variants (South African and Indian) and exploded at the beginning of the year 2022 (variant Omicron). Reunion has a specific island context both climato-geographically and demographically. Indeed, this French island located in the southern hemisphere in the middle of the Indian Ocean (OI) has a tropical climate and a multi-ethnic population, younger than in mainland France (16% are over 60 years old). It is also marked by a higher prevalence in the general population of certain risk factors, such as obesity (11%) and type 2 diabetes (\>10%), recognized as factors favoring severe clinical forms of COVID-19. as well as persistent COVID-19. This study will allow the constitution of a large-scale French cohort located in a closed overseas territory to provide answers to local specificities and to the management of the epidemic in the territory.

Interventions

OTHERtelephone interview 24 months after hospitalization for Covid-19

telephone interview 24 months after hospitalization for Covid-19

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years old * having been hospitalized at the University Hospital Center (CHU) of Reunion (minimum of one night in the hospital) * with a positive diagnosis of COVID-19 (positive RT(reverse transcription)-PCR(Polymerase Chain Reaction) SARS-CoV-2 on a nasopharyngeal swab or positive serology or confirmed diagnosis in the medical file) * registered in the COVIDEPI database * whose telephone numbers are available in the computerized patient file * residing on the island of Reunion * knowing how to understand and speak French

Exclusion criteria

* deceased * opposing the use of their data * deprived of liberty by judicial or administrative decision, minors, and persons subject to a legal protection measure: guardianship or curators

Design outcomes

Primary

MeasureTime frameDescription
cumulative incidence of patients with persistent COVID-1924 monthpresence (at the time of the interview or in the month preceding the interview) of at least one symptom among the most frequent prolonged symptoms of COVID-19 and which was not present before the interview SARS (severe acute respiratory syndrome )-CoV-2 infection

Secondary

MeasureTime frameDescription
Determine the factors associated with the persistence of symptoms24 month
Measure physical and mental quality of life24 monthMedical Outcome Study Short Form 12

Countries

Reunion

Contacts

Primary ContactLucie AUZANNEAU
lucie.auzanneau@chu-reunion.fr0262359949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026